InsidersTradesSigma
Follow the IRLAB Therapeutics AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, IRLAB Therapeutics AB has logged 24 public disclosures. Market capitalisation: €113m. The latest transaction was disclosed on 9 July 2026 (Purchase). Among the most active insiders: Joakim Tedroff. All data is openly available.
24
Insider Decl.
n/a
Thresholds
€1m
24 ops.
Buy Volume
n/a
n/a
Sell Volume
38Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 July 2026
Declarations24 total
10,500 shares@ €0.140.014% mcap2.3% of flowAktieISIN SE0012675361FI:csv-7a3c2db5bd0c5cc0c6bf
200,000 shares@ €0.150.28% mcap47.7% of flowAktieISIN SE0012675361FI:csv-4d1c5ffaada541c4ab44
10,500 shares@ €0.140.014% mcap4.7% of flowAktieISIN SE0012675361FI:csv-35717e7a0931ae76cb93
200,000 shares@ €0.150.28% mcap100.0% of flowAktieISIN SE0012675361FI:csv-844ff39e4cac1d0d42e2
97,369 shares@ SEK 1.200.10% mcap32.5% of flowAktieISIN SE0012675361FI:csv-75e3ad9e602aca825661
202,631 shares@ SEK 1.200.22% mcap67.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-22bfd22bba1034efbae4
140,716 shares@ SEK 1.200.15% mcap67.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-2c830c6519ddb45ef9a1
67,618 shares@ SEK 1.200.071% mcap32.5% of flowAktieISIN SE0012675361FI:csv-6afbe8f6601ec1188497
112,573 shares@ SEK 1.200.12% mcap67.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-a2fc0dc8407569dc4fe0
54,094 shares@ SEK 1.200.057% mcap32.5% of flowAktieISIN SE0012675361FI:csv-38d280ab09db282c0366
52,333 shares@ SEK 1.200.0052% mcap62.8% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-c6e5dad78154c1e4dd97
31,000 shares@ SEK 1.200.0031% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-d7e8a96b42391e08e898
183,858 shares@ SEK 1.200.018% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-df7cf2154fe892975198
4,016,742 shares@ SEK 1.200.41% mcap88.1% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-fd654d5a64a63337a524
250,000 shares@ SEK 1.200.026% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-644fe006c9298328bad7
66,142 shares@ SEK 1.200.0068% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-7f4c847a7582f9e90c96
427,416 shares@ SEK 1.200.044% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-bc0ef732bc436e9724fa
555,842 shares@ SEK 1.200.55% mcap22.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-442236d17577c19fb895
555,842 shares@ SEK 1.200.057% mcap22.5% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:csv-042e9dab302a546e5d34
250,000 shares@ €0.18190.042% mcap78.2% of flowAktieISIN SE0012675361FI:A003U250-1
70,000 shares@ €0.18160.012% mcap21.8% of flowAktieISIN SE0012675361FI:A003U002-1
36,000 shares@ €0.31230.010% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003R127-1
357,327 shares@ €0.30960.10% mcap75.5% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q791-1
116,196 shares@ €0.30960.033% mcap24.5% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q787-1
24 of 24 declarations
Acerca de IRLAB Therapeutics AB
IRLAB Therapeutics AB es una empresa biofarmacéutica sueca centrada en el desarrollo de tratamientos para enfermedades neurodegenerativas. Cotiza en la Bolsa de Valores de Estocolmo (XSTO).